• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Pract Res . Spontaneous Intracerebral Hemorrhages in the Post-COVID-19 Period without Classical Risk Factors: Clinical Characteristics and Ou

tetano

Editor, Senior Moderator
J Clin Pract Res


. 2025 Nov 21;47(6):590-596.
doi: 10.14744/cpr.2025.63357. eCollection 2025 Nov.
Spontaneous Intracerebral Hemorrhages in the Post-COVID-19 Period without Classical Risk Factors: Clinical Characteristics and Outcomes

Cem Demirel[SUP] 1 [/SUP], Salih Buğra Yılmaz[SUP] 2 [/SUP], Recai Engin[SUP] 1 [/SUP], Fatih Tomakin[SUP] 1 [/SUP], Ali Şahin[SUP] 3 [/SUP], Derya Kılıç Köksal[SUP] 4 [/SUP], Vaner Köksal[SUP] 1 [/SUP]


Affiliations
Abstract

Objective: The objective of this article is to evaluate the clinical characteristics of spontaneous intracranial hemorrhages occurring in the post-COVID-19 (post-coronavirus disease 2019) period in patients without classical risk factors (hypertension, anticoagulant therapy, or vascular malformations) and to assess the concordance of these findings with the existing literature.
Materials and methods: Between 2020 and 2024, 36 patients with a prior history of COVID-19 who presented with spontaneous intracerebral hemorrhage were retrospectively reviewed. Cases were evaluated for age, sex, Glasgow Coma Scale (GCS), international normalized ratio (INR), hemorrhage type and anatomical location, modified Rankin Scale (mRS), rebleeding, and overall clinical outcomes. Patients with any macroscopic vascular pathology were excluded from the study.
Results: The mean age of the patients was 52.0 years, and 61.1% were male. The overall mortality rate was 47.2%. Parenchymal hemorrhages comprised 55.6% of cases, subarachnoid hemorrhages 22.2%, and subdural hemorrhages 22.2%. Subarachnoid hemorrhages exhibited the highest mortality rate (87.5%). The mean GCS score was 8.2, and the mean modified Rankin Scale score at one year was 4.3. The GCS score was significantly associated with mortality (p=0.0001), whereas INR and age showed no significant relationship (p=0.2923 and p=0.6003, respectively).
Conclusion: In the post-COVID-19 period, intracerebral hemorrhages occurring in patients without classical etiological factors represent a notable clinical entity. The high mortality and rates of functional dependency observed indicate that this patient group requires novel strategies for early diagnosis and long-term monitoring.

Keywords: COVID-19; Coagulopathy; functional outcomes; mortality; spontaneous intracerebral hemorrhage.

 
Back
Top